WEB Aneurysm Embolization System W2-9-5Recalls & reported problems
Sequent Medical, Inc. · WEB 27 SL 9x5 · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00856956005855), received between Mar 29, 2022 and Mar 29, 2022 — classified as 1 injury.
The most frequently reported specific device problem is “Activation Problem” (1 report).
1 other recall cover devices cleared under the same FDA submission (P170032); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Activation Problem1
- Difficult to Remove1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 29, 2022Difficult to Remove; Activation Problem; Difficult to Remove; Activation Problem
IT WAS REPORTED THAT DURING TREATMENT OF AN ACOMM ANEURYSM, A WEB DEVICE OPENED AT THE DISTAL THIRD, BUT THE PROXIMAL TWO THIRDS WERE NOT OPENED. THE WEB COULD NOT BE RESHEATED OR OPENED, AND WAS DEPLYED IN THE ANEURYSM NECK. A STENT WAS IMPLANTED TO KEEP THE A1 AND A2 OPEN. POST PROCEDURAL IMAGING REVEALED A RESIDUAL ANEURYSM, BUT FLOW TO THE PARENT VESSEL WAS OPEN. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13934930 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P170032. One submission often covers many models, so check the product and lot details in each record.
- Z-0170-2023 · Sep 21, 2022 · Open, ClassifiedWEB Detachment Controller, REF: WDC-2, WDC, MV-WDC2. Component of WEB Aneurysm Embolization System.
Other Intrasaccular Flow Disruption Device devices
- WEB Detachment Controller WDC-2-MVIMicrovention, Inc. · Intrasaccular Flow Disruption Device1 recall0 reports
- WEB W5-4-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death23 reports
- WEB 17 SL 6x2 W5-6-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death20 reports
- WEB W5-5-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device20 reports
- WEB W5-4.5-2-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device19 reports
- WEB W5-7-3-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death16 reports
- WEB W5-6-3-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device1 death15 reports
- WEB Aneurysm Embolization System W2-8-3-MVI-3Microvention, Inc. · Intrasaccular Flow Disruption Device14 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page